Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Cash generated from core business operations
5Y CAGR
+14.6%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $339.31M | +89.0% |
| 2025 | $179.55M | +138.8% |
| 2024 | $-462.85M | -200.8% |
| 2023 | $-153.89M | -13.0% |
| 2022 | $-136.13M | -179.5% |
| 2021 | $171.31M | +278.8% |
| 2020 | $-95.80M | -155.4% |
| 2019 | $173.03M | +466.4% |
| 2018 | $-47.22M | -97.3% |
| 2017 | $-23.94M | - |